| Trial ID: | L1447 |
| Source ID: | NCT01675089
|
| Associated Drug: |
Zoledronic Acid
|
| Title: |
Zoledronic Acid to Prevent Bone Loss After Kidney Transplantation
|
| Acronym: |
|
| Status: |
COMPLETED
|
| Study Results: |
NO
|
| Results: |
|
| Conditions: |
Renal Osteodystrophy
|
| Interventions: |
DRUG: Zoledronic acid
|
| Outcome Measures: |
Primary: Differences in bone turnover, Bone histomorphometric data will be analyzed at baseline and after 1 year of kidney transplantation., 1 year | Secondary: Bone microarchitecture, Bone microarchitecture will be examined by high-resolution peripheral quantitative computed tomography at the time of transplant and after 12 months., 1 year|Changes in Bone Mineral Density, Bone mineral density (BMD) measurements by dual-energy X-ray absorptiometry (DEXA) will be made at the time of transplant and after 6 and 12 months., 1 year
|
| Sponsor/Collaborators: |
Sponsor: University of Sao Paulo General Hospital
|
| Gender: |
ALL
|
| Age: |
ADULT, OLDER_ADULT
|
| Phases: |
PHASE4
|
| Enrollment: |
34
|
| Study Type: |
INTERVENTIONAL
|
| Study Designs: |
Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT
|
| Start Date: |
2012-07
|
| Completion Date: |
2014-05
|
| Results First Posted: |
|
| Last Update Posted: |
2014-05-19
|
| Locations: |
Hospital das Clinicas - Faculdade de Medicina da Universidade de São Paulo, Sao Paulo, 05403-900, Brazil
|
| URL: |
https://clinicaltrials.gov/show/NCT01675089
|
